n1mtc.com - NMTC Profit before deduction of interest, taxes, depreciation and amortization
NeuroOne Medical Technologies generates revenue through the sale of flexible sensors for brain activity analysis and minimally invasive instrumentation. Production capacities for thin-film devices operate at maximum efficiency upon the upgrading of photolithography equipment. The current EBITDA_Co level confirms the brand's reputation in neuromodulation, where electrode precision is critical for epilepsy treatment, and the indicator has reached the level of 0.00.
Summary analytical data breakdowns for NeuroOne Medical Technologies Corporation (NMTC)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio NeuroOne Medical Technologies|NMTC - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio NeuroOne|NMTC - Company Aggregate Debts|Debts to Book Value NeuroOne Medical Technologies|NMTC - Company Long-Term Debts|Company Short-Term Indebtedness NeuroOne Medical Technologies|Interim Coverage Ratio n1mtc.com
- earnings and market multiples details:
NMTC - Net Profit|Future Profit NeuroOne Medical Technologies|NMTC - P/E Multiple|Forward P/E Multiple n1mtc.com|NMTC - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Medical Technologies|NMTC - Operating profit before deduction of amortization|Earnings per share for the trailing year NeuroOne Medical Technologies|NMTC - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months n1mtc.com|NMTC - Earnings per share growth in current year|Net earnings per one share growth forecast for next year NeuroOne Medical Technologies
Summary company analytics:NeuroOne Medical Technologies
Absolute operating profit is used to assess the financial stability of NeuroOne Medical Technologies (NMTC), measuring cash flow from core operations before interest and taxes to demonstrate the business's actual ability to generate cash. By analyzing the EBITDA history, an investor can see how regulatory barriers and the complexities of commercializing neurosurgical systems directly impact the operating efficiency and overall liquidity of NeuroOne Medical Technologies (NMTC).
Who NeuroOne Medical Technologies competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences Inc.|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED) - Operating profit EBITDA|Embecta Corp (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization Axogen Surgical AXGN|Operating profit EBITDA SIBN (SI-BONE, Inc.)|Operating profit EBITDA orthofix.com OFIX|BVS - Profit before payment of interest, taxes and amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical) - Operating profit before deduction of amortization|Strata Medical - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization rxsight.com RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Operating profit before depreciation charges|NeuroStar - Operating profit before deduction of amortization|Operating profit EBITDA Sight Sciences Inc SGHT|Orchestra BioMed, Inc. - Operating profit EBITDA|Operating income before deduction of amortization Anika Therapeutics ANIK|InspireMD (NSPR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZJYL (Jin Medical)|Profit before payment of interest, taxes and amortization Vivani Medical Inc|Operating profit before deduction of amortization Xtant Medical Inc (XTNT)|Operating profit EBITDA MODD|MYO - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Envoy Medical COCH|VVOS: Operating profit before amortization|NVNO: Operating profit before deduction of amortization|Sintx Technologies - Company profit before taxes, interest and amortization|Tenon Medical, Inc. (TNON) - Profit before payment of interest, taxes and amortization|Operating profit before amortization LFWD|AMIX (Autonomix Medical Inc.) - Operating profit EBITDA|Profit before interest, taxes and amortization INVO Bioscience IVF|Operating profit before deduction of amortization BBLG (Bone Biologics Corporation)|Operating profit EBITDA Axonics, Inc (AXNX)|Profit before payment of interest, taxes and amortization BIOLASE, Inc. BIOL|Income before deduction of interest, taxes and amortization DYNT|FNA - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization INVO Bioscience, Inc.
